Agreement to explore Optimer vehicles for targeted delivery of siRNA

FHS
July 9, 2024
8:22 am

New collaboration will evaluate Aptamer’s fibrotic liver delivery vehicles with siRNA.

UK Government expands opioid overdose treatment access

The latest development aims to save lives by enabling quicker responses to opioid overdoses among vulnerable populations. Credit: New2me86 / Shutterstock.com. The UK Government is

May 14, 2024

Silence Therapeutics announces $120m private placement

Share this article Zerlasiran and divesiran is being analysed to treat cardiovascular risks and haematological diseases, respectively. Credit: S_L / Shutterstock.com. Silence Therapeutics has announced

February 6, 2024

FDA puts Kezar lupus trial on hold after earlier report of patient deaths

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.